Retirement Systems of Alabama Has $25.47 Million Stake in Encompass Health Co. (NYSE:EHC)

Retirement Systems of Alabama increased its position in shares of Encompass Health Co. (NYSE:EHC) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 275,804 shares of the company’s stock after purchasing an additional 268 shares during the period. Retirement Systems of Alabama owned approximately 0.27% of Encompass Health worth $25,470,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB grew its stake in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares in the last quarter. UMB Bank n.a. boosted its holdings in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC grew its position in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new position in shares of Encompass Health during the third quarter worth approximately $40,000. Finally, Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $46,000. 97.25% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial restated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Price Performance

EHC stock opened at $102.18 on Thursday. The stock has a market cap of $10.29 billion, a price-to-earnings ratio of 24.68, a P/E/G ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The company has a 50 day simple moving average of $96.43 and a 200 day simple moving average of $95.08. Encompass Health Co. has a 1 year low of $71.79 and a 1 year high of $104.55.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.